Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-157-8 | CAS number: 1758-73-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Repeated dose toxicity oral: NOAEL (m, f): 20 mg/kg bw/day (OECD 422, GLP)
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 20 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Aminoiminomethanesulphinic acid was administered at doses of 4, 20 and 100 mg/kg bw/day in Crj:CD (SD) IGS male and female rats to study repeated dose toxicity and developmental toxicity for parental animals, and reproductive/developmental toxicity in pups due to OECD assessment for existing chemicals in a screening test conducted according to OECD 422 and under GLP conditions. Males were orally administered 14 days before mating, 35 days during and after mating. Females were orally administered during mating period, pregnancy period and until 3 days of lactation. No mortality was observed in animals. Loss of fur was observed in one male and two females at dose of 100 mg/kg. Body weight gain was suppressed after dosing 100 mg/kg in both sexes. In this group, food consumption was also decreased.
Hematological findings of male rats showed a decrease in erythrocyte and hematocrit, an increase in reticulocyte, and a reduction of prothrombin time and APTT.
Myelogram findings of male rats in the 100 mg/kg bw treatment group showed a decrease in nucleated cells, M/E ratio, neutrophil, eosinophil, lymphocyte, basophilic erythroblast, and poly- and orthochrome erythroblast.
Biochemical findings of male rats at doses of more than 20 mg/kg bw/day administered groups showed a decrease in ALP. In the 100 mg/kg bw administered group, albumin, A/G ratio, triglycerides, phospholipids, total bilirubin, BUN, creatinine, inorganic phosphorus and calcium were increased. Glucose, GOT, GPT and potassium were decreased in the 100 mg/kg group bw
An increase in liver and spleen weight was found in males and females of the 100 mg/kg bw group. Organ weight of testis was also increased in this group.
With regard to histopathological findings, hepatocyte hypertrophy of centrilobular, basophilic material in bile duct, vacuolar degeneration of hepatocyte, and hemosiderin deposit of Kupffer cells were observed in males and females of the 100 mg/kg bw group. In kidney, tubular necrosis was observed in only one female of the 100 mg/kg bw group. Basophilic tubule was observed in males and females of the 100 mg/kg bw group. Some of these cases showed also cellular infiltration of lymphocyte and tubule dilatation. Erosion or ulcer of glandular stomach was observed in males and females of the 100 mg/kg bw group. This effect may be related to the irritant properties of the substance. Extramedullary hematopoiesis and hemosiderin deposit of red pulp was observed in both sexes of the 100 mg/kg bw/group. Decreased hematopoiesis of femur bone marrow was observed in males in the 100 mg/kg bw group. Besides, dilatation of seminiferous tubule, degeneration of germ cell, multinucleated giant cell, vacuolization of Sertoli cell, seminiferous tubule atrophy and spermatic granuloma were observed in testis in the 100 mg/kg bw group.
In addition, necrosis of hepatocyte, accumulation of foam cell, mineralization of artery, hemorrhage of lungs and thymus, myocardial degeneration, atrophy of seminiferous tubule, granuloma of spermatic of testis and epididymis were regarded as not relevant toxicological effect but changes caused naturally.
On the basis of the above exposed the NOAEL for the repeated dose toxicity is considered to be 20 mg/kg bw/day for males and females.
In addition aminoiminomethanesulphinic acid was tested in a subacute test according to OECD guideline 407. Groups of 5 male and 5 female Wistar rats each received once per day on 5 days per week during 4 consecutive weeks an oral dose of the test compound per gavage. Doses were 0, 15, 47 and 150 mg/kg body weight per day (OECD SIDS 2002). Changes observed in the high dose group (150 mg/kg bw/day) included reduced body weight gain, reduced food consumption, raised fur, reduction of serum levels of cholesterol, glucose and alkaline phosphatase, elevation of serum levels of bilirubin and inorganic phosphate, reduced weights of the thymus. In the mid dose group only a decrease of serum alkaline phosphatase was found. Histopathological analysis did not reveal unequivocally substance related effects. Since the decreased alkaline phosphatase at the mid dose level was an isolated effect it was concluded that the No-Adverse-Effect-Level was 47 mg aminoiminomethanesulphinic acid per kg body weight in both sexes of rats.
On the basis of the data above exposed aminoiminomethanesulphinic acid (CAS 1758-73-2) meet the criteria for classification STOT RE 2, H373 according to Regulation (EC) No 1272/2008 or Xn, R48/22 according to Directive 67/548/EEC on the basis of the hematological and biochemical changes.
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Test conditions according to GLP and standard method
Justification for classification or non-classification
The available data on the repeated dose toxicity of aminoiminomethanesulphinic acid (CAS 1758-73-2) meet the criteria for classification STOT RE 2, H373 according to Regulation (EC) No 1272/2008 or Xn, R48/22 according to Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.